Neurologic Findings Among Inpatients With COVID-19 at a Safety-net US Hospital
| Autor: | Lan Zhou, Pria Anand, Davidson H. Hamer, David M. Greer, Nahid Bhadelia, Anna M. Cervantes-Arslanian |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Pediatrics
medicine.medical_specialty Exacerbation Coronavirus disease 2019 (COVID-19) business.industry Research Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Neurointensive care 03 medical and health sciences 0302 clinical medicine Altered Mental Status Modified Rankin Scale medicine Etiology 030212 general & internal medicine Neurology (clinical) Neurologic Findings business 030217 neurology & neurosurgery |
| Zdroj: | Neurol Clin Pract |
| ISSN: | 2163-0933 2163-0402 |
| Popis: | ObjectiveTo characterize the breadth of neurologic findings associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in a diverse group of inpatients at an urban, safety-net US medical center.MethodsPatients were identified through an electronic medical record review from April 15, 2020, until July 1, 2020, at a large safety-net hospital in Boston, MA, caring primarily for underserved, low-income, and elderly patients. All hospitalized adult patients with positive nasopharyngeal swab or respiratory PCR testing for SARS-CoV-2 during their hospitalization or in the 30 days before admission who received an inpatient neurologic or neurocritical care consultation or admission during the study period were enrolled.ResultsSeventy-four patients were identified (42/57% male, median age 64 years). The majority of patients self-identified as Black or African American (38, 51%). The most common neurologic symptoms at presentation to the hospital included altered mental status (39, 53%), fatigue (18, 24%), and headache (18, 18%). Fifteen patients had ischemic strokes (20%). There were 10 in-hospital mortalities, with moderately severe disability among survivors at discharge (14%, median modified Rankin Scale score of 4).ConclusionsNeurologic findings spanned inflammatory, vascular pathologies, sequelae of critical illness and metabolic derangements, possible direct involvement of the nervous system by SARS-CoV-2, and exacerbation of underlying neurologic conditions, highlighting a broad range of possible etiologies of neurologic complications in patients with coronavirus disease 2019 (COVID-19). Further studies are needed to characterize the infectious and postinfectious neurologic complications of COVID-19 in diverse patient populations. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|